Revenue, 2023 (US$M)
$0.0
Forecast, 2030 (US$M)
$0.0
CAGR, 2024 - 2030
0%
Report Coverage
Mexico

Mexico tissue diagnostics market highlights

  • The Mexico tissue diagnostics market generated a revenue of USD 50.1 million in 2023 and is expected to reach USD 109.7 million by 2030.
  • The Mexico market is expected to grow at a CAGR of 11.8% from 2024 to 2030.
  • In terms of segment, immunohistochemistry was the largest revenue generating technology in 2023.
  • Digital Pathology and Workflow is the most lucrative technology segment registering the fastest growth during the forecast period.


Tissue diagnostics market data book summary

Market revenue in 2023USD 50.1 million
Market revenue in 2030USD 109.7 million
Growth rate11.8% (CAGR from 2023 to 2030)
Largest segmentImmunohistochemistry
Fastest growing segmentDigital Pathology and Workflow
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationImmunohistochemistry, In situ Hybridization, Primary & Special Staining, Digital Pathology and Workflow, Anatomic Pathology
Key market players worldwideRoche Holding AG ADR, Abbott Laboratories, Thermo Fisher Scientific Inc, Siemens AG, Danaher Corp, BioMerieux SA, Qiagen NV, BD, Merck KGaA, GE Aerospace, Agilent Technologies Inc, Biogenex, Cell Signaling Technology, Bio SB, DiaGenic


Other key industry trends

  • In terms of revenue, Mexico accounted for 0.9% of the global tissue diagnostics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil tissue diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • Mexico is the fastest growing regional market in Latin America and is projected to reach USD 109.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Tissue Diagnostics Market Companies

Name Profile # Employees HQ Website

Mexico tissue diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tissue diagnostics market will help companies and investors design strategic landscapes.


Immunohistochemistry was the largest segment with a revenue share of 30.14% in 2023. Horizon Databook has segmented the Mexico tissue diagnostics market based on immunohistochemistry, in situ hybridization, primary & special staining, digital pathology and workflow, anatomic pathology covering the revenue growth of each sub-segment from 2018 to 2030.


Mexican market for diagnostics and sequencing technologies has witnessed good growth in the last decade mostly owing to the technological advancements, increasing entry of multinational companies and rapid expansion of path labs aided by government aid.

These trends coupled with emergence of local players, increasing expenditure by the government and rapid growth in research facilities are expected to propel the market in the forecast period. As the market is highly competitive, many of the international & domestic companies are looking to offer better, reliable & faster technologies and purer reagents which in turn would help bring down the prices of the platform and this would help improve the penetration and adoption of newer technologies.

Reasons to subscribe to Mexico tissue diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Mexico tissue diagnostics market databook

  • Our clientele includes a mix of tissue diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Mexico tissue diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Mexico tissue diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Mexico tissue diagnostics market

Mexico Tissue Diagnostics Market Outlook Share, 2023 & 2030 (US$M)

Mexico tissue diagnostics market

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more